詳細検索

詳細検索

お問い合わせ

Varicose Vein Market Insights, Competitive Landscape, and Market Forecast - 2033

Varicose Vein Market Insights, Competitive Landscape, and Market Forecast - 2033


The global varicose vein market is gaining steady momentum as the incidence of chronic venous disorders continues to rise worldwide. Varicose veins, commonly affecting the lower limbs, are increasi... もっと見る

 

 

出版社
Fairfield Market Research
フェアフィールドマーケットリサーチ
出版年月
2026年4月29日
電子版価格
US$4,995
シングルユーザライセンス
ライセンス・価格情報/注文方法はこちら
納期
通常5営業日以内
ページ数
194
言語
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

Summary

The global varicose vein market is gaining steady momentum as the incidence of chronic venous disorders continues to rise worldwide. Varicose veins, commonly affecting the lower limbs, are increasingly prevalent due to aging demographics, sedentary work patterns, and growing obesity rates. As awareness surrounding vascular health improves, more patients are seeking timely diagnosis and treatment. The healthcare sector is also witnessing a transition from conventional surgical procedures to minimally invasive techniques, which offer enhanced safety, quicker recovery, and improved patient outcomes. This shift is playing a crucial role in redefining the competitive landscape of the varicose vein market.

Market Insights

The varicose vein market is projected to reach USD 1.6 billion in 2026 and is anticipated to grow to USD 2.5 billion by 2033, expanding at a CAGR of 6.4% during the forecast period. This consistent growth is largely attributed to the increasing adoption of advanced treatment modalities such as endovenous laser therapy and radiofrequency ablation. These procedures are becoming the preferred choice among healthcare professionals due to their precision and reduced post-procedure complications. Additionally, the integration of advanced imaging technologies is improving diagnostic accuracy and treatment planning, further supporting market growth.

Market Drivers

A major factor driving the varicose vein market is the growing aging population, which is more susceptible to venous insufficiency. Lifestyle-related risk factors such as prolonged standing, lack of physical activity, and unhealthy dietary habits are also contributing to the increasing prevalence of varicose veins. As urbanization continues to rise, these factors are becoming more widespread, particularly in developing regions.

Technological advancements in minimally invasive procedures are significantly boosting market demand. Treatments such as endovenous ablation and sclerotherapy are increasingly favored due to their effectiveness and shorter recovery periods. Patients are more inclined toward these procedures as they minimize hospital stays and allow for quicker return to daily activities. Furthermore, increasing awareness campaigns and improved access to healthcare services are encouraging early diagnosis and treatment, thereby driving market expansion.

Business Opportunity

The varicose vein market presents lucrative opportunities for medical device manufacturers and healthcare providers. The growing demand for minimally invasive treatments is encouraging companies to invest in research and development to introduce innovative and efficient treatment solutions. Continuous advancements in laser technologies and catheter-based procedures are expected to create new revenue streams for market participants.

Emerging economies are expected to offer significant growth potential due to improving healthcare infrastructure and rising disposable incomes. The expansion of ambulatory surgical centers and specialty clinics is also providing new platforms for delivering cost-effective treatments. Strategic partnerships and collaborations among key players are further enhancing product development and market reach, enabling companies to strengthen their global footprint.

Region Analysis

North America continues to lead the varicose vein market, supported by well-established healthcare systems, high patient awareness, and widespread adoption of advanced treatment technologies. The presence of major industry players and favorable reimbursement scenarios further contribute to the region’s dominance.

Europe holds a substantial share of the market, driven by an increasing elderly population and rising demand for minimally invasive procedures. Countries across the region are focusing on enhancing healthcare services and adopting innovative treatment solutions, which is supporting steady market growth.

Asia Pacific is expected to witness the fastest growth over the forecast period. Rapid urbanization, increasing healthcare investments, and growing awareness about vascular health are key factors driving the market in this region. Additionally, the rising popularity of medical tourism is encouraging patients to seek advanced treatments at competitive costs.

Latin America and the Middle East & Africa are gradually emerging as potential markets. Improvements in healthcare access, coupled with increasing awareness and adoption of modern treatment methods, are expected to support growth in these regions.

Key Players

The global varicose vein market is characterized by intense competition, with key players focusing on innovation and strategic expansion to maintain their market position. Prominent companies operating in the market include:

• Medtronic plc

• AngioDynamics, Inc.

• Boston Scientific Corporation

• biolitec AG

• Merit Medical Systems

• Teleflex Incorporated

• Lumenis Ltd.

• Dornier MedTech GmbH

• Quanta System S.p.A.

• Alma Lasers Ltd.

• Sciton, Inc.

• Candela Medical

• LeMaitre Vascular

• Theraclion SA

• VVT Medical Ltd.

These organizations are actively engaged in product development, technological advancements, and partnerships to enhance their offerings and expand their global presence.

Segmentation

By Type

• Endovenous Ablation

o Endovenous Laser Therapy

o Radiofrequency Ablation

• Injection Sclerotherapy

• Surgical Ligation & Stripping

By End-use

• Hospitals

• Ambulatory Surgical Centers

• Specialty Clinics

By Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East & Africa

ページTOPに戻る


Table of Contents

1. Executive Summary
1.1. Global Varicose Vein Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2026
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. COVID-19 Impact Analysis
2.5. Porter's Five Forces Analysis
2.6. Impact of Russia-Ukraine Conflict
2.7. PESTLE Analysis
2.8. Regulatory Analysis
2.9. Price Trend Analysis
2.9.1. Current Prices and Future Projections, 2025-2033
2.9.2. Price Impact Factors
3. Global Varicose Vein Market Outlook, 2020-2033
3.1. Global Varicose Vein Market Outlook, by Type, Value (US$ Bn), 2020-2033
3.1.1. Endovenous Ablation
3.1.1.1. Endovenous Laser Therapy
3.1.1.2. Radiofrequency Ablation
3.1.2. Injection Sclerotherapy
3.1.3. Injection Sclerotherapy
3.2. Global Varicose Vein Market Outlook, by End-use, Value (US$ Bn), 2020-2033
3.2.1. Hospitals
3.2.2. Ambulatory Surgical Centers
3.2.3. Specialty Clinics
3.3. Global Varicose Vein Market Outlook, by Region, Value (US$ Bn), 2020-2033
3.3.1. North America
3.3.2. Europe
3.3.3. Asia Pacific
3.3.4. Latin America
3.3.5. Middle East & Africa
4. North America Varicose Vein Market Outlook, 2020-2033
4.1. North America Varicose Vein Market Outlook, by Type, Value (US$ Bn), 2020-2033
4.1.1. Endovenous Ablation
4.1.1.1. Endovenous Laser Therapy
4.1.1.2. Radiofrequency Ablation
4.1.2. Injection Sclerotherapy
4.1.3. Injection Sclerotherapy
4.2. North America Varicose Vein Market Outlook, by End-use, Value (US$ Bn), 2020-2033
4.2.1. Hospitals
4.2.2. Ambulatory Surgical Centers
4.2.3. Specialty Clinics
4.3. North America Varicose Vein Market Outlook, by Country, Value (US$ Bn), 2020-2033
4.3.1. U.S. Varicose Vein Market Outlook, by Type, 2020-2033
4.3.2. U.S. Varicose Vein Market Outlook, by End-use, 2020-2033
4.3.3. Canada Varicose Vein Market Outlook, by Type, 2020-2033
4.3.4. Canada Varicose Vein Market Outlook, by End-use, 2020-2033
4.4. BPS Analysis/Market Attractiveness Analysis
5. Europe Varicose Vein Market Outlook, 2020-2033
5.1. Europe Varicose Vein Market Outlook, by Type, Value (US$ Bn), 2020-2033
5.1.1. Endovenous Ablation
5.1.1.1. Endovenous Laser Therapy
5.1.1.2. Radiofrequency Ablation
5.1.2. Injection Sclerotherapy
5.1.3. Injection Sclerotherapy
5.2. Europe Varicose Vein Market Outlook, by End-use, Value (US$ Bn), 2020-2033
5.2.1. Hospitals
5.2.2. Ambulatory Surgical Centers
5.2.3. Specialty Clinics
5.3. Europe Varicose Vein Market Outlook, by Country, Value (US$ Bn), 2020-2033
5.3.1. Germany Varicose Vein Market Outlook, by Type, 2020-2033
5.3.2. Germany Varicose Vein Market Outlook, by End-use, 2020-2033
5.3.3. Italy Varicose Vein Market Outlook, by Type, 2020-2033
5.3.4. Italy Varicose Vein Market Outlook, by End-use, 2020-2033
5.3.5. France Varicose Vein Market Outlook, by Type, 2020-2033
5.3.6. France Varicose Vein Market Outlook, by End-use, 2020-2033
5.3.7. U.K. Varicose Vein Market Outlook, by Type, 2020-2033
5.3.8. U.K. Varicose Vein Market Outlook, by End-use, 2020-2033
5.3.9. Spain Varicose Vein Market Outlook, by Type, 2020-2033
5.3.10. Spain Varicose Vein Market Outlook, by End-use, 2020-2033
5.3.11. Russia Varicose Vein Market Outlook, by Type, 2020-2033
5.3.12. Russia Varicose Vein Market Outlook, by End-use, 2020-2033
5.3.13. Rest of Europe Varicose Vein Market Outlook, by Type, 2020-2033
5.3.14. Rest of Europe Varicose Vein Market Outlook, by End-use, 2020-2033
5.4. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Varicose Vein Market Outlook, 2020-2033
6.1. Asia Pacific Varicose Vein Market Outlook, by Type, Value (US$ Bn), 2020-2033
6.1.1. Endovenous Ablation
6.1.1.1. Endovenous Laser Therapy
6.1.1.2. Radiofrequency Ablation
6.1.2. Injection Sclerotherapy
6.1.3. Injection Sclerotherapy
6.2. Asia Pacific Varicose Vein Market Outlook, by End-use, Value (US$ Bn), 2020-2033
6.2.1. Hospitals
6.2.2. Ambulatory Surgical Centers
6.2.3. Specialty Clinics
6.3. Asia Pacific Varicose Vein Market Outlook, by Country, Value (US$ Bn), 2020-2033
6.3.1. China Varicose Vein Market Outlook, by Type, 2020-2033
6.3.2. China Varicose Vein Market Outlook, by End-use, 2020-2033
6.3.3. Japan Varicose Vein Market Outlook, by Type, 2020-2033
6.3.4. Japan Varicose Vein Market Outlook, by End-use, 2020-2033
6.3.5. South Korea Varicose Vein Market Outlook, by Type, 2020-2033
6.3.6. South Korea Varicose Vein Market Outlook, by End-use, 2020-2033
6.3.7. India Varicose Vein Market Outlook, by Type, 2020-2033
6.3.8. India Varicose Vein Market Outlook, by End-use, 2020-2033
6.3.9. Southeast Asia Varicose Vein Market Outlook, by Type, 2020-2033
6.3.10. Southeast Asia Varicose Vein Market Outlook, by End-use, 2020-2033
6.3.11. Rest of SAO Varicose Vein Market Outlook, by Type, 2020-2033
6.3.12. Rest of SAO Varicose Vein Market Outlook, by End-use, 2020-2033
6.4. BPS Analysis/Market Attractiveness Analysis
7. Latin America Varicose Vein Market Outlook, 2020-2033
7.1. Latin America Varicose Vein Market Outlook, by Type, Value (US$ Bn), 2020-2033
7.1.1. Endovenous Ablation
7.1.1.1. Endovenous Laser Therapy
7.1.1.2. Radiofrequency Ablation
7.1.2. Injection Sclerotherapy
7.1.3. Injection Sclerotherapy
7.2. Latin America Varicose Vein Market Outlook, by End-use, Value (US$ Bn), 2020-2033
7.2.1. Hospitals
7.2.2. Ambulatory Surgical Centers
7.2.3. Specialty Clinics
7.3. Latin America Varicose Vein Market Outlook, by Country, Value (US$ Bn), 2020-2033
7.3.1. Brazil Varicose Vein Market Outlook, by Type, 2020-2033
7.3.2. Brazil Varicose Vein Market Outlook, by End-use, 2020-2033
7.3.3. Mexico Varicose Vein Market Outlook, by Type, 2020-2033
7.3.4. Mexico Varicose Vein Market Outlook, by End-use, 2020-2033
7.3.5. Argentina Varicose Vein Market Outlook, by Type, 2020-2033
7.3.6. Argentina Varicose Vein Market Outlook, by End-use, 2020-2033
7.3.7. Rest of LATAM Varicose Vein Market Outlook, by Type, 2020-2033
7.3.8. Rest of LATAM Varicose Vein Market Outlook, by End-use, 2020-2033
7.4. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Varicose Vein Market Outlook, 2020-2033
8.1. Middle East & Africa Varicose Vein Market Outlook, by Type, Value (US$ Bn), 2020-2033
8.1.1. Endovenous Ablation
8.1.1.1. Endovenous Laser Therapy
8.1.1.2. Radiofrequency Ablation
8.1.2. Injection Sclerotherapy
8.1.3. Injection Sclerotherapy
8.2. Middle East & Africa Varicose Vein Market Outlook, by End-use, Value (US$ Bn), 2020-2033
8.2.1. Hospitals
8.2.2. Ambulatory Surgical Centers
8.2.3. Specialty Clinics
8.3. Middle East & Africa Varicose Vein Market Outlook, by Country, Value (US$ Bn), 2020-2033
8.3.1. GCC Varicose Vein Market Outlook, by Type, 2020-2033
8.3.2. GCC Varicose Vein Market Outlook, by End-use, 2020-2033
8.3.3. South Africa Varicose Vein Market Outlook, by Type, 2020-2033
8.3.4. South Africa Varicose Vein Market Outlook, by End-use, 2020-2033
8.3.5. Egypt Varicose Vein Market Outlook, by Type, 2020-2033
8.3.6. Egypt Varicose Vein Market Outlook, by End-use, 2020-2033
8.3.7. Nigeria Varicose Vein Market Outlook, by Type, 2020-2033
8.3.8. Nigeria Varicose Vein Market Outlook, by End-use, 2020-2033
8.3.9. Rest of Middle East Varicose Vein Market Outlook, by Type, 2020-2033
8.3.10. Rest of Middle East Varicose Vein Market Outlook, by End-use, 2020-2033
8.4. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Company Vs Segment Heatmap
9.2. Company Market Share Analysis, 2025
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Medtronic plc
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Developments
9.4.2. AngioDynamics, Inc.
9.4.3. Boston Scientific Corporation
9.4.4. biolitec AG
9.4.5. Merit Medical Systems
9.4.6. Teleflex Incorporated
9.4.7. Lumenis Ltd.
9.4.8. Dornier MedTech GmbH
9.4.9. Quanta System S.p.A.
9.4.10. Alma Lasers Ltd.
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療IT)の最新刊レポート


よくあるご質問


Fairfield Market Research社はどのような調査会社ですか?


Fairfield Market Researchでは、最新かつ最も関連性の高い市場データと洞察に満ちた詳細なレポートを発行しています。広範囲にわたり、業界動向や市場ベースのデータを含んでおり、顧客が... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。


詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

 

2026/06/02 10:27

160.76 円

187.28 円

219.02 円

ページTOPに戻る